Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic ArthritisJurgen Sota, Luca Cantarini, Alma Nunzia Olivieri et al.|Frontiers in Pharmacology|2019Cited by 616
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter surveyAndrea Taddio, Marco Cattalini, Sara Della Paolera et al.|Pediatric Rheumatology|2021Cited by 126
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational StudyAntonio Vitale, Luca Cantarini, Antonella Insalaco et al.|Frontiers in Pharmacology|2016Cited by 88
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Jurgen Sota, Antonio Vitale et al.|Clinical Rheumatology|2018Cited by 82
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-<i>α</i> Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA NetworkCarla Gaggiano, Luca Cantarini, Antonio Vitale et al.|Mediators of Inflammation|2020Cited by 49